MESOBLAST LTD — Foreign Filer Report 2018

Jul 24, 2018

6-K 1 meso-6k_20180718.htm 6-K HTML PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd" meso-6k_20180718.htm NG Converter v5.0.18157.137

UNITED STATES SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

Form 6-K

Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934

For the month of July 2018

Commission File Number 001-37626

Mesoblast Limited

( Exact name of Registrant as specified in its charter )

Not Applicable

( Translation of Registrant’s name into English)

Australia ( Jurisdiction of incorporation or organization)

Silviu Itescu

Chief Executive Officer and Executive Director

Level 38

55 Collins Street

Melbourne 3000

Australia

( Address of principal executive offices )

Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F:

Form 20-F ☑ Form 40-F ☐

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1):

Yes ☐ No ☑

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7):

Yes ☐ No ☑

INFORMATION CONTAINED ON THIS REPORT ON FORM 6-K

On July 18, 2018, Mesoblast Limited submitted an Initial Director’s Interest Notice Form to the Australian Securities Exchange, a copy of which is attached to this report as Exhibit 99.1

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly organized.

Mesoblast Limited
/s/ Charlie Harrison
Charlie Harrison
Company Secretary

Dated: July 23, 2018

INDEX TO EXHIBITS

Item
99.1	Initial Director’s Interest Notice, Shawn Cline Tomasello .